AzTrials
AzTrials

Frail Elderly SyndromeSPAANCT03141866

Seated Physical Activity in Ageing

A study testing Exercise Intervention 1: Move It Or Lose It (MIOLI) and Exercise Intervention 2: Machine-based resistance training intervention in people with Frail Elderly Syndrome and Frailty, run by University of Birmingham at 1 site in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This trial will take the form of a feasibility study; designed to assess the feasibility of a proposed future clinical trial in this setting. This proposed future clinical trial is proposed to assess the impact of physical activity, in the form of specialised chair based physical activity interventions, on the… Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Frail Elderly Syndrome, Frailty, Physical Activity
What is being tested?
Exercise Intervention 1: Move It Or Lose It (MIOLI) and Exercise Intervention 2: Machine-based resistance training intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteUnited Kingdom
Study dates
3 Sep 2018to 9 Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Temporary residents within the Harborne 'living lab' ward of the Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, United Kingdom
  • ≥ 65 years of age
  • Frail according to the Fried Frailty criteria: meeting at least three of the five characteristics of frailty (Fried et al. 2001)
  • Have the capacity to speak and read in English
  • Anticipated by their care team to remain on the ward for approximately 14 days post enrolment into the study. This will be advised by the patient's care team.

Who cannot join

  • Currently taking part in any other clinical trial which could potentially have an impact upon or influences the findings of the current study
  • Currently terminally ill with life expectancy which is less than the duration of the study's interventions
  • Severe sensory impairment which would profoundly impact on their capacity to undergo the interventions, even once appropriate adaptations have been made.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site, 1 recruiting
  • Harborne Ward, Queen Elizabeth Hospital Birmingham

    Birmingham, West Midlands, B15 2TH

    Dr. Zoe Wyrko, zoe.wyrko@uhb.nhs.uk

    Dr. Thomas Jackson, t.jackson@bham.ac.uk

    Recruiting

Other trials in United Kingdom

About this study

Official title: "Determining the Feasibility of Chair-based Physical Activity Interventions, Aimed at Improving Various Aspects of Health and Wellbeing in Geriatric Populations With Pre-existing Frailty, Within a Hospital Ward Setting"

This trial will take the form of a feasibility study; designed to assess the feasibility of a proposed future clinical trial in this setting. This proposed future clinical trial is proposed to assess the impact of physical activity, in the form of specialised chair based physical activity interventions, on the physiological, psychological, cognitive, social and emotional health, and functional capacity of geriatric populations with pre-existing frailty within a clinical hospital ward setting; recognising health as a holistic concept incorporating a multitude of inter-related dimensions. This feasibility study is single-centre (taking place in the Harborne Ward of the Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Edgbaston, Birmingham, United Kingdom).

Being tested
Exercise Intervention 1: Move It Or Lose It (MIOLI), Exercise Intervention 2: Machine-based resistance training intervention
Medical subject headings
Frailty, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise Intervention 1: Move It Or Lose It (MIOLI)Other

    An established chair-based physical activity programme for older adults.

  • Exercise Intervention 2: Machine-based resistance training interventionOther

    Specialised, chair-based, pneumatic resistance training equipment for older adults.

Study groups in NCT03141866
Study groupRoleWhat they receive
Exercise Intervention 1: Move It Or Lose It (MIOLI)ExperimentalAn established chair-based physical activity programme for older adults.
Receives: Other: Exercise Intervention 1: Move It Or Lose It (MIOLI)
Exercise Intervention 2: Machine-based resistance trainingExperimentalSpecialised, chair-based resistance training equipment for older adults.
Receives: Other: Exercise Intervention 2: Machine-based resistance training intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility

    The primary dependent variable of this feasibility study will relate to the eight primary areas of focus of feasibility studies (Bowen et al. 2009), relating to:

    • Acceptability
    • Demand
    • Implementation
    • Practicality
    • Adaptation
    • Integration
    • Expansion and
    • Limited-efficacy testing

    These eight aforementioned areas (constituting the one variable of feasibility) will serve as the primary dependent variable for this study, in order to establish the feasibility of a proposed future clinical trial within this setting. The dependent variable of feasibility will be assessed through semi-structured interviews with participants post intervention, while focus groups will be utilised with both the intervention implementers and study support staff in order to assess the primary dependent variable of the study. Participant uptake and adherence records will also be employed throughout.

    Measured: Post-Intervention (2 weeks)

Secondary outcomes (17)
  1. Cortisol (Physiological Dependent Variable)

    Measured: Pre-intervention (baseline), and post-intervention (2 weeks)

  2. Dehydroepiandrosterone-sulphate (DHEAS) (Physiological Dependent Variable)

    Measured: Pre-intervention (baseline), and post-intervention (2 weeks)

  3. Serum cortisol : DHEAS ratio (Physiological Dependent Variable)

    Measured: Pre-intervention (baseline), and post-intervention (2 weeks)

  4. C-reactive proteins (CRP) (Physiological Dependent Variable)

    Measured: Pre-intervention (baseline), and post-intervention (2 weeks)

  5. Inflammatory Cytokine: Interleukin 6 (IL-6) (Physiological Dependent Variable)

    Measured: Pre-intervention (baseline), and post-intervention (2 weeks)

  6. Inflammatory Cytokine: Tumor Necrosis Factor alpha (TNFα) (Physiological Dependent Variable)

    Measured: Pre-intervention (baseline), and post-intervention (2 weeks)

  7. Inflammatory Cytokine: Interferon gamma (IFNy) (Physiological Dependent Variable)

    Measured: Pre-intervention (baseline), and post-intervention (2 weeks)

  8. Hand grip strength (Functional Dependent Variable)

    Measured: Pre-intervention (baseline), and post-intervention (2 weeks)

  9. Leg strength (Functional Dependent Variable)

    Measured: Pre-intervention (baseline), and post-intervention (2 weeks)

  10. Leg power output (Functional Dependent Variable)

    Measured: Pre-intervention (baseline), and post-intervention (2 weeks)

  11. Short Physical Performance Battery (SPPB) (Functional Dependent Variable)

    Measured: Pre-intervention (baseline), and post-intervention (2 weeks)

  12. Katz Index of Independence in Activities of Daily Living (Katz ADL) (Functional Dependent Variable)

    Measured: Pre-intervention (baseline), and post-intervention (2 weeks)

  13. Fried Frailty Phenotype (Functional Dependent Variable)

    Measured: Pre-intervention (baseline), and post-intervention (2 weeks)

  14. Geriatric Depression Scale (GDS) (Psychological Dependent Variable)

    Measured: Pre-intervention (baseline), and post-intervention (2 weeks)

  15. Hospital Anxiety Depression Scale (HADS) (Psychological Dependent Variable)

    Measured: Pre-intervention (baseline), and post-intervention (2 weeks)

  16. Standardized Mini-Mental State Examination (SMMSE) (Cognitive Dependent Variable)

    Measured: Pre-intervention (baseline), and post-intervention (2 weeks)

  17. Interpersonal Support Evaluation List (ISEL) (Social Dependent Variable)

    Measured: Pre-intervention (baseline), and post-intervention (2 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 May 2017
  2. Study start3 Sep 2018
  3. Primary completion9 Aug 2019 (estimated)
  4. Study completion9 Aug 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03141866
Sponsor's protocol ID
ERN_16-0986S
Other IDs
675003
Acronym
SPAA
Status last verified
Apr 2019
First submitted
21 Apr 2017
Last updated
26 Jul 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, Bakken S, Kaplan CP, Squiers L, Fabrizio C, Fernandez M. How we design feasibility studies. Am J Prev Med. 2009 May;36(5):452-7. doi: 10.1016/j.amepre.2009.02.002.

    PubMed 19362699
  • Doody P, Lord JM, Greig CA, Whittaker AC. Assessing the feasibility and impact of specially adapted exercise interventions, aimed at improving the multi-dimensional health and functional capacity of frail geriatric hospital inpatients: protocol for a feasibility study. BMJ Open. 2019 Nov 21;9(11):e031159. doi: 10.1136/bmjopen-2019-031159.

    PubMed 31753876

Questions about this trial

What is this clinical trial studying?

A study testing Exercise Intervention 1: Move It Or Lose It (MIOLI) and Exercise Intervention 2: Machine-based resistance training intervention in people with Frail Elderly Syndrome and Frailty, run by University of Birmingham at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mr. Paul Doody (+44 (0) 121 414 ext. 4125, p.d.doody@bham.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility (time frame: Post-Intervention (2 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03141866, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jul 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in